Varnisam-1 Tablet (Varenicline Tartrate 1 mg.)

What is Varnisam-1 Tablet (Varenicline Tartrate 1 mg.)?

Varnisam-1 Tablet contains varenicline tartrate, a prescription medication approved to help adults stop smoking. It works by targeting nicotine receptors in the brain, reducing the pleasurable effects of smoking and easing withdrawal symptoms. Unlike nicotine replacement therapies, Varnisam-1 does not contain nicotine. It is typically taken over a 12-week course, with dosage gradually increasing during the first week.

Key features

• Active Ingredient — Varenicline tartrate 1 mg. per tablet.
• Prescription-Based — Requires medical evaluation and ongoing supervision.
• Non-Nicotine Formula — Helps quit smoking without replacing nicotine.
• Dual Action — Reduces cravings and blocks nicotine’s rewarding effects.
• Structured Regimen — Designed for a 12-week treatment plan with clear dosing schedule.
• Oral Tablet — Convenient once-daily dosing after initial titration.
• Manufactured to Standards — Produced under strict quality controls for consistency and safety.

Who is Varnisam-1 Tablet (Varenicline Tartrate 1 mg.) for?

This medication is intended for adult smokers seeking a medically supported path to quit. It is not recommended for individuals under 18, pregnant or breastfeeding women, or those with severe kidney impairment without physician guidance. Ideal candidates are motivated to quit and able to adhere to a prescribed treatment timeline.

How does Varnisam-1 Tablet (Varenicline Tartrate 1 mg.) compare?

Compared to nicotine patches or gums, Varnisam-1 offers a non-nicotine alternative that both reduces cravings and diminishes smoking satisfaction. It differs from bupropion (Zyban) in mechanism, targeting nicotine receptors more directly. While behavioral therapies support mindset change, Varnisam-1 provides pharmacological intervention, often yielding higher success rates when combined with counseling.